Filing Details

Accession Number:
0001570562-18-000051
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-05 17:08:16
Reporting Period:
2018-06-04
Accepted Time:
2018-06-05 17:08:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1570562 Evolus Inc. EOLS Pharmaceutical Preparations (2834) 461385614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1730224 Bosun Hau 17901 Von Karman Avenue,
Suite 150
Irvine CA 92614
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-04 7,142 $29.19 7,142 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The shares were purchased in multiple trades at prices ranging from $28.93 to $29.3899. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.